98 related articles for article (PubMed ID: 2385259)
1. Rats immunized with cholinergic synaptosomes: a model for Lambert-Eaton syndrome.
Chapman J; Rabinowitz R; Korczyn AD; Michaelson DM
Muscle Nerve; 1990 Aug; 13(8):726-33. PubMed ID: 2385259
[TBL] [Abstract][Full Text] [Related]
2. [Immunologic aspects of disorders of neuromuscular transmission. 2. Experimental autoimmune myasthenia gravis and the Lambert-Eaton myasthenic syndrome].
Andreis I; Lovnićki TJ; Beara N; Taradi M
Lijec Vjesn; 1994; 116(5-6):158-61. PubMed ID: 7968205
[TBL] [Abstract][Full Text] [Related]
3. Synaptotagmin can cause an immune-mediated model of Lambert-Eaton myasthenic syndrome in rats.
Takamori M; Hamada T; Komai K; Takahashi M; Yoshida A
Ann Neurol; 1994 Jan; 35(1):74-80. PubMed ID: 8285596
[TBL] [Abstract][Full Text] [Related]
4. Autoimmune disorders of neuromuscular transmission.
Mahadeva B; Phillips LH; Juel VC
Semin Neurol; 2008 Apr; 28(2):212-27. PubMed ID: 18351523
[TBL] [Abstract][Full Text] [Related]
5. Specificity of Lambert-Eaton myasthenic syndrome immunoglobulin for nerve terminal calcium channels.
Hewett SJ; Atchison WD
Brain Res; 1992 Dec; 599(2):324-32. PubMed ID: 1363289
[TBL] [Abstract][Full Text] [Related]
6. An autoimmune animal model of the Lambert-Eaton syndrome.
Kim YI; Middlekauff EH; Viglione MP; Okutsu J; Satoh Y; Hirashima N; Kirino Y
Ann N Y Acad Sci; 1998 May; 841():670-6. PubMed ID: 9668312
[No Abstract] [Full Text] [Related]
7. Immunization of rats with cholinergic neurons induces behavioral deficits.
Chapman J; Feldon J; Alroy G; Michaelson DM
J Neural Transplant; 1989; 1(2):63-76. PubMed ID: 2519521
[TBL] [Abstract][Full Text] [Related]
8. Lambert-Eaton myasthenic syndrome: search for alternative autoimmune targets and possible compensatory mechanisms based on presynaptic calcium homeostasis.
Takamori M
J Neuroimmunol; 2008 Sep; 201-202():145-52. PubMed ID: 18653248
[TBL] [Abstract][Full Text] [Related]
9. [Ultrastructural study on neuromuscular junction of patients with lambert-Eaton myasthenia syndrome or mitochondrial encephalomyopathy].
Song D; Shi J; Lü Q
Zhonghua Yi Xue Za Zhi; 1998 Jul; 78(7):512-4. PubMed ID: 10923460
[TBL] [Abstract][Full Text] [Related]
10. [Lambert-Eaton myasthenic syndrome, an immune pathology of neuromuscular junctions].
Honnorat J
Bull Acad Natl Med; 2014 Feb; 198(2):243-54; discussion 255. PubMed ID: 26263702
[TBL] [Abstract][Full Text] [Related]
11. Serum and plasma from patients with Lambert-Eaton Myasthenic Syndrome reduce depolarization-dependent uptake of 45Ca2+ into rat cortical synaptosomes.
Hewett SJ; Atchison WD
Brain Res; 1991 Dec; 566(1-2):320-4. PubMed ID: 1814548
[TBL] [Abstract][Full Text] [Related]
12. Disruption of synaptosomal calcium channel function by Lambert-Eaton myasthenic immunoglobulin is serum-dependent.
Hewett SJ; Atchison WD
Brain Res; 1992 Dec; 599(2):317-23. PubMed ID: 1363288
[TBL] [Abstract][Full Text] [Related]
13. Lambert-Eaton myasthenic syndrome: mouse passive-transfer model illuminates disease pathology and facilitates testing therapeutic leads.
Meriney SD; Tarr TB; Ojala KS; Wu M; Li Y; Lacomis D; Garcia-Ocaña A; Liang M; Valdomir G; Wipf P
Ann N Y Acad Sci; 2018 Jan; 1412(1):73-81. PubMed ID: 29125190
[TBL] [Abstract][Full Text] [Related]
14. Lambert-Eaton myasthenic syndrome in childhood.
Kostera-Pruszczyk A; Ryniewicz B; Rowinska-Marcinska K; Dutkiewicz M; Kamińska A
Eur J Paediatr Neurol; 2009 Mar; 13(2):194-6. PubMed ID: 18585938
[TBL] [Abstract][Full Text] [Related]
15. Favorable response to rituximab in a patient with anti-VGCC-positive Lambert-Eaton myasthenic syndrome and cerebellar dysfunction.
Pellkofer HL; Voltz R; Kuempfel T
Muscle Nerve; 2009 Aug; 40(2):305-8. PubMed ID: 19609921
[TBL] [Abstract][Full Text] [Related]
16. [Cyclosporin A in the treatment of Eaton-Lambert myasthenic syndrome].
Yuste Ara JR; Beloqui Ruiz O; Artieda Gonzalez-Granda J; Herrero Santos JI; De la Peña Fernandez A; Prieto Valtueña J
An Med Interna; 1996 Jan; 13(1):25-6. PubMed ID: 8679819
[TBL] [Abstract][Full Text] [Related]
17. Presynaptic effects of immunoglobulin G from patients with Lambert-Eaton myasthenic syndrome: their neutralization by intravenous immunoglobulins.
Buchwald B; Ahangari R; Weishaupt A; Toyka KV
Muscle Nerve; 2005 Apr; 31(4):487-94. PubMed ID: 15685615
[TBL] [Abstract][Full Text] [Related]
18. [Neurogenic electromyographic activity in a patient with non-paraneoplasic Lambert-Eaton syndrome].
Lapergue B; Lefaucheur JP; Bourahoui A; Nordine T; Hosseini H; Créange A
Rev Neurol (Paris); 2007 Dec; 163(12):1227-31. PubMed ID: 18355470
[TBL] [Abstract][Full Text] [Related]
19. SOX1 antibodies are markers of paraneoplastic Lambert-Eaton myasthenic syndrome.
Sabater L; Titulaer M; Saiz A; Verschuuren J; Güre AO; Graus F
Neurology; 2008 Mar; 70(12):924-8. PubMed ID: 18032743
[TBL] [Abstract][Full Text] [Related]
20. Action of Lambert-Eaton myasthenic syndrome IgG at mouse motor nerve terminals.
Prior C; Lang B; Wray D; Newsom-Davis J
Ann Neurol; 1985 Jun; 17(6):587-92. PubMed ID: 2992356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
